Immun Glob G(Igg)-Ifas/Glycine
Brand name: Panzyga
Rank #204 of 500 drugs by total cost
$70.1M
Total Cost
4,693
Total Claims
$70.1M
Total Cost
158
Prescribers
$15K
Cost per Claim
72
Beneficiaries
4,755
30-Day Fills
$443K
Avg Cost/Provider
30
Avg Claims/Provider
About Immun Glob G(Igg)-Ifas/Glycine
Immun Glob G(Igg)-Ifas/Glycine (sold as Panzyga) was prescribed 4,693 times by 158 Medicare Part D providers in 2023, costing the program $70.1M. At $15K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 201 | Fingolimod Hcl (Fingolimod) | $72.1M | 10,675 |
| 202 | Brivaracetam (Briviact) | $71.8M | 43,716 |
| 203 | Mirtazapine (Mirtazapine) | $70.2M | 3,166,739 |
| 204 | Immun Glob G(Igg)-Ifas/Glycine (Panzyga) | $70.1M | 4,693 |
| 205 | Buprenorphine Hcl (Buprenorphine Hcl) | $69.7M | 205,349 |
| 206 | Prednisolone Acetate (Prednisolone Acetate) | $68.8M | 1,486,663 |
| 207 | Tenofovir Alafenamide (Vemlidy) | $68.7M | 44,509 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology